Epicentrx, Inc.
Records under this name other than the patents Epicentrx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,664,247 | Acyclic Organonitro Compounds for Use in Treating Cancer now held by Northrop Grumman Systems Corporation In force · High confidence | In force | High confidence | |
| US 7,507,842 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Term ended Aug 11, 2026 · High confidence | Term ended | Term ended Aug 11, 2026 | High confidence |
| US 8,299,053 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Term ended Aug 11, 2026 · High confidence | Term ended | Term ended Aug 11, 2026 | High confidence |
| US 8,927,527 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Ended no later than Aug 11, 2026 · Medium confidence | Term ended | Ended no later than Aug 11, 2026 | Medium confidence |
| US 9,226,915 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Term ended Aug 11, 2026 · High confidence | Term ended | Term ended Aug 11, 2026 | High confidence |
| US 10,149,832 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Ended no later than Aug 11, 2026 · Medium confidence | Term ended | Ended no later than Aug 11, 2026 | Medium confidence |
| US 11,925,617 | Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof and Uses Thereof now held by Northrop Grumman Systems Corporation Term ended Term ended Aug 11, 2026 · Low confidence | Term ended | Term ended Aug 11, 2026 | Low confidence |
| US 9,987,270 | Treatment of Gliomas Using Organonitro Compound Combination Therapy Lapsed on the fee record Ended Jun 5, 2026 · High confidence | Lapsed on the fee record | Ended Jun 5, 2026 | High confidence |
| US 11,253,608 | Recombinant Adenoviruses Carrying Transgenes Lapsed on the fee record Ended Feb 22, 2026 · High confidence | Lapsed on the fee record | Ended Feb 22, 2026 | High confidence |
| 12/019,460 | Treatment of Headaches, Neck Pain, Joint Pain and Inflammatory-Type Pain Abandoned Abandoned Sep 24, 2015 | Abandoned | Abandoned Sep 24, 2015 |